wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38636718-FF654CEC-F8D3-4937-A270-B2CE380D707D
Q38636718-FF654CEC-F8D3-4937-A270-B2CE380D707D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38636718-FF654CEC-F8D3-4937-A270-B2CE380D707D
Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents.
P2860
Q38636718-FF654CEC-F8D3-4937-A270-B2CE380D707D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38636718-FF654CEC-F8D3-4937-A270-B2CE380D707D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a97ccc9e69db3ce62541c7e527ea4e10a9e5009
P2860
Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer